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Polycystic Ovarian Syndrome (PCOS) is a physiological disorder that causes many negative 
effects involving a variety of systems in the body, such as the endocrine, metabolic, 
psychological, and reproductive systems. This paper will explore the complex mechanisms 
behind the manifestation of PCOS and how these, and other factors, may make diagnosis 
difficult. In order to thoroughly understand these aspects of PCOS, the causes, symptoms, and 
treatments were explored. The diversity of causes and symptoms of the disease add to the 
difficulty in diagnosis and treatment of PCOS. The best treatment option varies among 
individuals, and the effectiveness of each treatment can vary according to an individual’s 
condition. The research on all of these aspects of PCOS will inform the public about how PCOS 
can affect them and their loved ones. From this newly gathered knowledge, individuals may be 
able to protect themselves from some of the negative consequences associated with PCOS.  
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resistance, endocrine, Quality of Life (QoL), Psychological aspects of PCOS 
 
  
  iii 
TABLE OF CONTENTS 
I. INTRODUCTION…………………………………………….. 1 
II. CAUSES………………………………………………………. 2 
III. SYMPTOMS…………………………………………………... 7 
IV. SPECIFICALLY PSYCHOLOGICAL SYMPTOMS……10 
V. DIAGNOSIS…………………………………………………... 20 
VI. ASSOCIATED DISORDERS...……………………………….. 24 
VII. TREATMENT…………………………………………………. 25 
VIII. LIFESTYLE MODIFICATION AS TREATMENT…………... 29 









 I would like to thank Dr. Suzanne Byrd for all her guidance throughout this entire 
process.  I would not have been able to successfully complete my thesis, especially 
not to the caliber that it is, without the helpful advice and expertise. She has given me 
advice that I can carry with me and put into practice in all my future endeavors. 
Thank you to all the faculty, staff, friends, and family that have been my support 
system throughout this whole process
    
 
Polycystic Ovarian Syndrome, commonly known as PCOS, is an endocrine disorder seen 
in women of reproductive age (Scalzo & McKittrick, 2000). The endocrine system involves 
chemical signaling in the body. Hormones or other chemical signals may be sent out by the 
endocrine system in response to a certain stimuli, and the release of these chemicals then leads to 
certain processes being turned on or off in the body. It is a system of control, as it works to keep 
our body in a steady rhythm of balance. Polycystic Ovarian Syndrome is estimated to affect four 
to twelve percent of women throughout the world and is most commonly characterized by 
hyperandrogenism and insulin resistance, each of which affect sixty to eighty percent of PCOS 
patients and fifty to eighty percent of PCOS women, respectively (Sheehan, 2004; Garad et al., 
2011).  
 PCOS is the most common endocrine disorder among women of reproductive age, with 
symptoms of PCOS being seen in pre-pubertal girls, in some cases, and post-menopausal 
women, in many instances (Thomson et al., 2011). One source calculated that, in the U.S. alone, 
about four million women, ages fifteen to forty-four, are currently affected by PCOS; this source 
also noted that this was a very conservative estimate due to the low prevalence rate that was used 
in the source (Azziz, 2007).   
 The common age of onset for PCOS is adolescence while the common time of diagnosis 
is during a woman's third or fourth decade of life because the majority of symptoms do not 
become evident until a woman reaches her twenties or thirties, even though some symptoms may 
appear starting at menarche (Dunaif, 1997). Although PCOS is an endocrine disease, it affects 
many systems of the body resulting in reproductive, metabolic, and psychological consequences 
(Garad et al., 2011).  
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 This endocrine disorder was first identified in 1935 by Stein and Leventhal who noticed a 
condition in women characterized by irregular menstruation, obesity, and hirsutism, in addition 
to cysts on the women's ovaries. Before this time, PCOS was present, but people did not realize 
what they were seeing. These women were considered "freaks" and often known as "the bearded 
lady," commonly seen in circus acts or portrayed in certain art work (Kitzinger & Willmott, 
2002). Today, much more is known about this common condition, and the recently gathered 
knowledge includes various diagnostic procedures, a lengthened list of signs and symptoms, 
multiple treatment options, possible causes, and related conditions (Sheehan, 2004). While 
research has made great discoveries, it is important to remember that this knowledge really needs 
to be shared, especially with those who may potentially be affected by this syndrome. Research 
has shown that most of the general public is uninformed about this common disorder, and it has 
been recognized that very little information is available in sources that are easily accessible to 
the average citizen (Kitzinger & Willmott, 2002). Many women diagnosed with PCOS complain 
about receiving inadequate information about the disorder, even after a diagnosis has been made 
(Ching et al., 2007). If women are to protect themselves against this condition and its negative 
consequences, information about PCOS must be available to the general public.  
 Researchers, as well as the general public, lack a lot of the answers to important PCOS 
questions. Currently, the cause or causes of PCOS remain unknown. There are many theories, 
with much evidence pointing towards a genetic link because of the appearance of PCOS in 
clusters of female relatives and the presence of PCOS in certain individuals before their first 
menstruation (Franks et al., 2006). The hypothesis of a genetic link is also supported by the fact 
that both obese and lean PCOS women display insulin resistance which shows that there is an 
intrinsic defect in the action of insulin for PCOS women, although it is more common and more 
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severe in obese patients (Dunaif, 1997). The exact pathophysiology of PCOS is very complex 
and remains largely unknown. There are many suggested etiologies for the development of 
PCOS. While none of the currently proposed hypotheses have full experimental support, what 
has become clear is that there is an underlying hormonal imbalance that is created by a 
combination of increased androgens and the effects of insulin resistance. It has also been 
discovered that there are genetic and environmental factors that contribute to this hormonal 
imbalance, and these factors contribute to PCOS when combined with ovarian dysfunction, 
hypothalamic pituitary abnormalities, and obesity (Garad et al., 2011).  
 The imbalance found in PCOS involves estrogen, progesterone and androgens, such as 
testosterone ("Polycystic Ovary Syndrome," 2013). Androgens are considered to be the "male 
hormones" because they are seen in greater quantities in males, although a small amount of these 
are needed by women in order to carry out certain vital tasks such as building and maintaining 
bone and muscle mass. Biochemical features of PCOS include elevated androgens, particularly 
testosterone, lutenizing hormone (LH), estrogen, insulin levels and decreased Sex-hormone 
binding globulin (SHBG) levels (Tsilchorozidou, 2004). These biochemical levels are extremely 
important because SHBG normally binds to testosterone to transport it throughout the body, and 
while some testosterone is needed in women, too much free or unbound testosterone leads to 
many problems such as the hirsutism, acne, and male-patterned hair loss seen in many PCOS 
patients. When it is found that the free testosterone levels are increased and the SHBG levels are 
decreased, a person’s hormones must be regulated in order to help the woman manage her excess 
levels of androgens, and in turn, her PCOS symptoms (Roush, 2010). This excess testosterone is 
produced primarily in the ovaries and is caused by increased luteinizing hormone (LH) 
stimulation from the pituitary and the effect of hyperinsulinemia at the ovary (Sheehan, 2004). In 
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addition, LH and insulin are important hormones due to their involvement in the production of 
androgens by the ovaries and the necessity of LH in maintaining a woman’s normal menstrual 
cycle (Roush, 2010). 
  The genetic component of PCOS may involve the development of ovarian structure and 
function at an early stage of life, possibly in utero, during ovarian development and oogenesis 
(Franks et al., 2006).  Oogenesis is the process of formation of the female gametes, oocytes 
(“Medical Dictionary,” 2013). Evidence supporting a genetic basis for PCOS, and its associated 
hyperandrogenism and hyerinsulinemia, has been found in a variety of studies. Certain studies 
observed girls who displayed PCOS symptomology before their first period. Additional 
supporting research studies found PCOS to occur in clusters of relatives, including siblings 
(Franks et al., 2006).  
 While many studies support a genetic link, the mode of inheritance remains unclear, with 
only projected answers to that question and no agreed upon explanation (Franks et al., 2006). It 
is most likely that the cause is oligogenic or polygenic, meaning that it is a hereditary 
characteristic that is produced by one or only a few genes, or by several genes, respectively 
(“Medical Dictionary,” 2013). Multiple genes may be involved, while it is also possible for the 
cause to be an autosomal dominant mechanism (Franks et al., 2006) An autosomal dominant 
mechanism of inheritance refers to a trait that is inherited without respect to sex, meaning it does 
not involve a sex chromosome (“Medical Dictionary,” 2013). Genes that are being considered as 
the source of the defect or defects are genes involved in the androgen biosynthetic pathway, 
genes that affect the action and/or secretion of insulin, and genes that influence folliculogenesis 
(Franks et al., 2006).  
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 As the influence of specific genes remains veiled in ambiguity, the importance of Insulin 
Resistance's (IR) influence on PCOS patients has been recognized (Moran et al., 2003). Many 
scientists suggest a link between androgen levels and insulin levels (Tsilchorozidou, 2004). 
Insulin directly stimulates thecal cells to produce androgens, and elevated levels of androgens are 
related to many of the problems or symptoms seen in PCOS. Insulin also causes a decrease in the 
production of hepatic Sex Hormone Binding Globulin (SHBG) (Moran et al., 2003).  The 
hyperinsulinemia seen in PCOS most likely results from increased secretion of basal insulin 
along with decreased hepatic insulin clearance, but why this occurs is not completely understood 
(Dunaif, 1997). Basal insulin refers to the lowest possible level of insulin (“Medical Dictionary,” 
2013). Through its effects of increasing androgen production and decreasing hepatic SHBG 
production, insulin is a major contributor to hyperandrogenism and its associated clinical 
manifestations. This proposed relationship has been supported by research which found that 
reduced androgens were seen with improvements in insulin sensitivity, fertility, and menstrual 
regularity (Moran et al., 2003).  In another study, hyperinsulinemia was seen in PCOS women, 
independent of obesity, and the PCOS women with hyperinsulinemia showed a significant linear 
correlation between insulin and androgen levels. Additional results from this same study also 
suggest that hyperinsulinemia has an impact on ovarian morphology and function because a 
positive correlation was seen between hyperinsulinemia and ovarian stromal hyperthecosis 
(Dunaif, 1997). Ovarian stromal hyperthecosis involves islands of luteinized theca cells and 
excessive hyperplasia within the ovarian stroma which means that an excessive transformation of 
mature ovarian follicles into a corpus luteum and an abnormal increase in the number of normal 
cells in the typical arrangement of the supporting tissue of the ovaries has taken place (Dunaif, 
1997; “Medical Dictionary,” 2013).  
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 There may also be a defect in the insulin receptors in which the receptors are unable to 
adequately carry out phosphorylation of the substrate because the serine phosphorylation of the 
insulin receptor inhibits the tyrosine kinase activity of the receptor which affects signaling that 
involves insulin. This defect may be the cause behind the insulin resistance in PCOS women, but 
why or how this defect occurs remains a mystery (Dunaif, 1997).  
 The exact etiology of this defect is currently unidentified, but it has been discovered that 
defects found in the insulin receptors are not related to sex hormone levels, meaning that the 
irregularities involving insulin are intrinsic. From this same study, it was also gathered that 
fibroblasts from PCOS women exhibited no change in the binding or receptor affinity of insulin, 
but there was a decreased insulin receptor autophosphorylation in fifty percent of fibroblasts of 
the PCOS women (Dunaif, 1997).While some studies point to the insulin receptors, others state 
that there is a defect in insulin action that does not involve the receptor but rather occurs 
somewhere along the process in which the role of the receptor has already been carried out. The 
reason behind this hypothesis is because it coincides with the molecular research results that 
show no structural abnormalities in the insulin receptors (Tsilchorozidou, 2004).  In addition, a 
pancreatic B-cell secretory dysfunction has been found in PCOS. This dysfunction involves a 
defect in which Beta cells in the pancreas do not properly and effectively make insulin (“Medical 
Dictionary, 2013”) The pancreatic B-cell dysfunction that is present leads to insufficient insulin 
secretion, and even when weight loss occurs, the B-cell dysfunction remains, which suggests that 
the B-cell abnormality may be the primary irregularity in PCOS (Tsilchorozidou, 2004).   
  Another important question regarding PCOS and its etiology is how the maternal 
environment may affect the fetus. It is likely that the development of PCOS is due primarily to a 
genetic predisposition for the fetal ovary to hypersecrete androgens. While it is possible for the 
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maternal environment to affect the fetus, it is more likely that the placenta will prevent the 
maternal androgen excess from directly affecting the fetus; however, maternal metabolic 
disturbances, such as insulin resistance and glucose intolerance could affect the development of 
PCOS in the fetus. An example of this would be the effect of gestational diabetes on increased 
birth weight. Although the degree to which the maternal external environment affects the fetus is 
still unclear, much evidence has been found for the importance of fetal life as the time of origin 
for the development of PCOS. Certain studies involving animals, particularly rhesus monkeys, 
support this proposal because observations of rhesus monkeys suggest that exposure of the fetal 
hypothalamic-pituitary ovarian axis to excess androgens can lead to a sequence of events which 
result in both the reproductive and metabolic consequences of PCOS (Franks et al., 2006). The 
fetal hypothalamic-pituitary ovarian axis refers to the effects of the hypothalamus, pituitary 
gland, and ovaries on the fetus and how they relate to development and regulation of a number of 
body systems (“Medical Dictionary,” 2013). Furthermore, exogenous androgens have been 
shown to affect ovarian follicular development both in the rhesus monkey and in the sheep 
(Franks et al., 2006). Due to the complexity and heterogeneity of the disease, many professionals 
hypothesize that there are multiple pathophysiological mechanisms at work in PCOS 
(Tsilchorozidou, 2004).  
 As mentioned previously, PCOS affects many different body systems which is seen in the 
numerous and varied symptoms associated with the disease. An individual may present with a 
variety of reproductive, metabolic, and psychological problems. Reproductive problems may 
include infertility and various pregnancy complications and clinical signs of androgen excess. 
Metabolic problems may include insulin resistance, metabolic syndrome, impaired glucose 
tolerance (abnormal glucose metabolism), Diabetes Mellitus two, and potentially cardiovascular 
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disease (Garad et al., 2011). Metabolic syndrome refers to a condition in which an individual has 
two of the following health problems: increased triglycerides, decreased High Density 
Lipoprotein (HDL), increased fasting glucose levels, hypertension, and abdominal obesity 
(“Medical Dictionary,” 2013). Psychological problems may include reduced quality of life, poor 
self-esteem, depression, anxiety, and possibly eating disorders (Garad et al., 2011). 
 Hyperandrogenism is a primary hallmark of PCOS, and it shows up clinically as 
hirsutism, moderate to severe acne in adolescence or development or persistence of acne into 
adulthood, male pattern alopecia, and skin tags (Sheehan, 2004; Huber-Buchholz et al., 1999). 
These elevated testosterone levels also lead to menstrual irregularities, recurrent miscarriages, 
fetal abnormalities, obesity, primarily abdominal, and infertility (Sheehan, 2004; Huber-
Buchholz et al., 1999).  
 The majority of PCOS women have irregular periods with menstruation being very 
erratic, infrequent, or painful, with an increase in flow and cramping. Chronic anovulation may 
present as oligomenorrhea, amenorrhea, dysfunctional uterine bleeding, and/or infertility 
(Sheehan, 2004).  Oligomenorrhea refers to infrequent or very light menstruation while 
amenorrhea refers to the absence of menstrual periods for three or more months in a row 
(“Medical Dictionary,” 2013). Reproductive symptoms may include anovulation and 
miscarriages, among other things. One source stated that seventy five percent of anovulatory 
infertility is due to PCOS, and that PCOS women have a thirty to fifty percent first trimester 
miscarriage rate (Sheehan, 2004) while another noted that seventy to ninety percent of oligo-
ovulatory infertility is caused by PCOS, making PCOS the most common cause of this type of 
infertility. A certain document went as far as to say that PCOS is the most important single cause 
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of infertility in women because according to their research, fourteen to thirty two percent of 
infertile women have PCOS (Azziz, 2007).  
 A fair amount of PCOS women do have weight problems because of the metabolic 
abnormalities seen with the disease. Depending on the population looked at, sixteen to eighty 
percent of PCOS women are obese (Dunaif, 1997). Insulin resistance and metabolic syndrome 
may be seen in conjunction with high waist circumference, high Body Mass Index (BMI), and 
abnormal SHBG (Garad et al., 2011). Insulin resistance has also been known to cause acanthosis 
nigricans which are brown or black velvety patches of skin that appear hyperpigmented and are 
usually seen on the necks, thighs, and armpits of PCOS patients who have insulin resistance 
(Dunaif, 1997). Insulin resistance, obesity, and PCOS form a vicious cycle because one can 
cause the others, be caused by the others, and make the others worse. IR is very common in 
PCOS; however, a woman can have PCOS without having IR because there are multiple PCOS 
phenotypes, and just like with any other PCOS symptoms, there are varying degrees of IR 
(Thomson et al., 2011).  
 In addition, to the clinical features of PCOS, the biochemical signs and symptoms may 
include elevated serum testosterone and luteinizing hormone (LH) levels, usually seen with, 
normal serum Follicle Stimulating Hormone (FSH) concentrations. A situation can also be seen 
in which some hirsute women with polycystic ovaries have normal serum concentrations of 
testosterone, but androgen production rates are increased (Franks et al., 2006). PCOS women 
with insulin-resistance also display increased insulin levels, and possibly elevated LDL and 
decreased HDL levels (Roush, 2010). With all of these life-changing and potentially distressing 
symptoms, it seems logical that PCOS would also have a substantial amount of psychological 
symptoms.  
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 The members of the general public who are aware of Polycystic Ovarian Syndrome are 
most acquainted with the physiological aspects of the disorder, but what many do not realize is 
that there is a large portion of PCOS symptoms that are psychological in nature. Various studies 
have looked at the incidence of depression, anxiety, body image, self-esteem, and eating 
disorders in patients with PCOS (Garad et al., 2011). Numerous studies have shown a reduced 
quality of life for PCOS women, and this poor quality of life infiltrates every part of a woman’s 
life. The psychological stress associated with PCOS has been found to cause sexual 
dissatisfaction, aggression, bodily pain, infertility, weight difficulties, menstrual irregularity, and 
poorer interpersonal functioning (Barnard et al., 2007; Kitzinger & Willmott, 2002). Hirsutism, 
menstrual irregularity, and infertility have been found to be the most distressing symptoms for 
the majority of PCOS women (Barnard et al., 2007; Kitzinger & Willmott, 2002). It has been 
discovered that PCOS has a more substantial negative impact on psychological quality of life 
(QoL) than other chronic condition including, but not limited to, asthma, epilepsy, diabetes, 
cardiac disease, and arthritis (Coffey et al., 2006).  
 Depression and anxiety are the two most studied psychological problems related to 
PCOS. These two psychological problems have been examined by looking at quality of life 
questionnaires administered to women diagnosed with PCOS. Numerous studies have found a 
greater incidence of depression and anxiety, with greater severity, in PCOS women (Garad et al., 
2011). A study conducted by Barnard et al. (2011) found that PCOS patients, including women 
taking and not taking anti-androgen medications, had lower Quality of Life scores, than women 
without PCOS, on all seven factors that were looked at using the modified PCOS questionnaire. 
These seven factors were: emotional disturbance, weight, infertility, acne, menstrual symptoms, 
menstrual predictability, and hirsutism. The results from this study indicated that weight was the 
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greatest contributing factor to the lower QoL scores, both in women without PCOS and those 
with PCOS. This study also compared those taking and not taking anti-androgens and found that 
the women taking anti-androgens usually had higher QoL scores than women not taking anti-
androgens, but, regardless of the circumstances, weight concerns had the greatest impact on QoL 
in the PCOS population. The proposed explanation for these results is that there are systematic 
differences between women taking and those choosing not to take anti-androgens.  In addition, 
there are many positive effects that come from the use of anti-androgens, and the combination of 
these two factors are likely the cause of the better quality of life seen in anti-androgen users. 
Two-thirds of the women investigated in this study who suffered from PCOS displayed some 
level of depression, and when depression was found, it was seen to be more severe in PCOS 
women. This same study actually found a two-fold increase in the prevalence rate of depression 
seen in women with PCOS versus those without.  The overall conclusion from this research was 
that there is a higher prevalence of depression and poor QoL in PCOS women, and the 
psychological aspects of PCOS need to be addressed in the diagnosis and treatment of each 
individual (Barnard et al., 2011).  
 Anti-androgens seem to have a positive impact on quality of life, and oral contraceptives 
have also been shown to lead to alleviation of psychological complications involved with PCOS 
(Barnard et al., 2011). Rasgon et al. (2003) found that PCOS women taking oral contraceptives 
(OCPs) were significantly less depressed than those not taking oral contraceptives. That same 
study noted that twenty-nine percent of PCOS patients taking OCPs displayed depression, 
compared to the sixty-six percent prevalence of depression in untreated PCOS patients (Rasgon, 
2003).  Another aspect of depression that has been looked at in women is the correlation between 
testosterone and depression. Weiner et al. (2004) found there to be curvilinear relationship 
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between testosterone levels and depression in women with and without PCOS. The most severe 
depression was associated with testosterone levels just outside the normal female range; 
testosterone levels higher or lower than this were associated with lower levels of depression 
(Weiner et al., 2004). The reasons behind this finding are not known, but more research is being 
done to look at the relationship between depression and testosterone levels in women.   
 Depression has particularly been associated with insulin resistance and Body Mass Index 
(BMI) in PCOS women (Rasgon, 2003). In the study conducted by Rasgon et al. (2003), the 
researchers found that ten percent of the general population has depressive symptoms and/or 
disorders while fifty percent of the PCOS women they sampled had results that indicated the 
presence of depression. Since insulin resistance usually leads to increased obesity, mood 
fluctuations, due to the body's sensitivity to changes in blood sugar, and BMI, it is logical to see 
this association between IR and PCOS markers. Research has indicated that insulin resistance is 
a cardinal feature in the pathophysiology of PCOS (Franks, 1995). Insulin also affects central 
serotonin (5-HT) levels; serotonin is an important neurotransmitter involved in depression 
(Figlewicz, 1999). Central 5-HT system dysregulation, that causes depression, may concurrently 
affect peripheral insulin sensitivity (Okamura et al., 2000). Peripheral insulin sensitivity refers to 
the failure of target tissues to increase glucose disposal in response to insulin (“Medical 
Dictionary,” 2013). The mechanism behind this is not understood, but it may possibly occur via 
some sort of behavioral and/or neuroendocrinologic pathway (Okamura et al., 2000).  While 
these explanations are not complete, experimentation points to the explanation that insulin 
resistance may be the common pathological link between depression and PCOS, and ongoing 
research is being conducted to try and determine the exact biochemical mechanism involved 
(Rasgon, 2003).  
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 Another correlation was found between body mass index (BMI) and quality of life with 
increased BMI being associated with poorer quality of life scores in the areas of physical 
function, role physical, bodily pain, general health, vitality, mental health, and the physical 
component score of social function, with more difficulties in psychological health for the PCOS 
women rather than problems pertaining to physical functioning. However, this study did not find 
a difference between “normal” and PCOS women in quality of life based on socioeconomic 
status, when comparing age and weight matched women with or without PCOS. It was found 
that there was a sixty-two point four percent psychological morbidity found in the PCOS women, 
compared to the twenty-six point four percent found in the group without PCOS (Ching et al., 
2007). Psychological morbidity refers to a departure from a state of psychological well being 
resulting from disease, illness, injury, or sickness (“Medical Dictionary,” 2013). This study used 
a questionnaire to assess quality of life and the levels of distress caused by particular symptoms 
seen in PCOS and then compared those results to women surveyed in the general population who 
do not have PCOS. Overall, the results of this study indicated that the PCOS population has 
impaired QoL and an increased incidence of psychological morbidity when compared with 
population norms. This source also noted that the long-term health implications of PCOS can 
affect an individual’s quality of life. These results were most likely brought about due to poor 
body image and decreased self-esteem which many PCOS women experience. This explanation 
is a tentative one, but this source did note that if this explanation is correct, then this needs to be 
addressed in treatment of PCOS women (Ching et al., 2007).  
  Strongly associated with BMI is body image distress. It has been discovered that the 
increased body image distress that is seen in PCOS often leads to increased depression and lower 
self-esteem which can bring about complications in the realms of symptomology and treatment 
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(Rosen & Reiter, 1996). One study indicated that the sample of PCOS women presented with a 
much higher incidence and degree of body image distress than that seen in women with 
comparable BMI who were also seeking “weight management interventions” (Sarwer, 1998).  
Rosen and Reiter (1996) reported that seventy-one percent of PCOS women interviewed 
displayed clinically significant levels of body image distress, and more than half felt a persistent 
and unrelenting sense of unhappiness about their size, with the mean scores for the entire sample 
falling on or above the cut-off for clinically significant levels of body image disturbances. These 
results support the idea that body image distress is a major issue for PCOS women. This key 
issue is often disregarded, and steps should be taken in treatment to address this psychological 
problem associated with PCOS.  
 One reason that PCOS can be very distressing is because diagnosis can be extremely 
frustrating with some women having to go through a long process of tests and doctors visits 
before finding out what is wrong with them. Because much is still unknown about PCOS, these 
women may not get the adequacy of answers that they were looking for. In addition, many PCOS 
women have stated that they did not receive enough, in-depth education and information about 
PCOS and all that it entails.  A certain study found evidence for the idea that reduced QoL in 
psychological domains, for PCOS women, is related to the quality of information that the patient 
had acquired about their disorder. Patients who believed they had received sufficient 
information, especially in the areas of hirsutism, mental disturbance, and long-term health, had 
significantly higher QoL scores (Ching et al., 2007).    Patients with PCOS also face many 
distressing symptoms, and while some research points to specific symptoms that lead women to 
increased depression and anxiety, the fact of the matter is that there are many complex hormonal, 
metabolic, and reproductive features of PCOS that make determination of the root cause of 
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depressive and anxious symptoms difficult to identify. Possible symptoms that are being 
investigated include insulin resistance, androgen levels, acne, hirsutism, obesity, and infertility 
(Garad et al., 2011).  
While psychological distress may not be able to be linked to one particular parameter of 
PCOS, it is certain that many PCOS symptoms are “painful, uncomfortable, unpredictable, and 
associated with characteristics that are culturally defined as unfeminine and undesirable” 
(Barnard et al., 2007, p. 2279). Barnard et al. conducted interviews with PCOS women in which 
the themes of “freakishness” and a perceived inability to conform to “normal” feminine 
parameters prevailed revealing that PCOS women have a negative perception of themselves 
because of certain symptoms experienced (Barnard et al., 2007). It has also been discovered that 
the patient’s perception of the severity of her symptoms is more important than assessment of the 
severity of symptoms carried out by a medical professional (Ching et al., 2007). The idea that 
personal perception is more important than medical assessment can lead to a vicious cycle 
involving a patient’s perception of symptoms and their psychological distress or morbidity. In 
addition to the impact that symptoms play on a patient’s psychological well-being, there are 
biochemical disturbances associated with PCOS that may lead to mood disturbances, although 
more research is needed in this area (Barnard et al., 2007).  
 Hirustism in particular has been found to have major implications for an individual’s 
quality of life and psychosocial wellbeing (Azziz, 2007). Multiple people have studied the 
psychological repercussions associated with hirsutism in PCOS women. A few of these studies 
include the research done by Sonino et al. (1993) and Barth et al. (1993). Sonino et al. (1993) 
identified greater anxiety, psychotic symptoms, and social phobia in hirsute women, while Barth 
et al. (1993) noted that twenty-seven percent of women undergoing treatment for hirsutism 
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exhibited psychological morbidity, and sixty-eight percent reported avoiding some social 
situations because of self-consciousness.  It has also been shown that self-reported problems with 
hirsutism are associated with poorer QoL, particularly social functioning because many PCOS 
patients are embarrassed about their hirsutism. This embarrassment leads these women to feel 
uncomfortable in certain situations and possibly even avoid them (Ching et al., 2007).  
 Menstrual irregularities and unpleasant menstrual symptoms have also been shown to be 
an area of great concern and distress. In one study, it was discovered that menstrual symptoms 
were the second biggest area of concern in PCOS women (Barnard et al., 2007).  
 Anovulation, a type of menstrual irregularity, can lead to many fertility problems, seen 
especially in PCOS women. Difficulties conceiving, pregnancy complications, and engagement 
in infertility treatment programs can be very psychological damaging for many individuals, and 
unsuccessful fertility treatments lead to increased levels of anxiety and depression in all women, 
but even more so in women with PCOS. This increased anxiety and depression is very important 
because it has been discovered that the higher levels of depression and/or anxiety are associated 
with a lower success rate for in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) 
treatment cycles (Galletly et al., 1996).  
 Many of the problems mentioned above lead to avoidance, whether its avoidance of 
physical activity, healthy eating habits, social situations or dating and romantic interests. One 
source mentioned a few studies related to the sexual desire and avoidance of romantic 
relationships seen in PCOS. Gorzynski and Katz (1977) found that sexual drive was heightened 
in women with PCOS. From these results, it was proposed that young PCOS women may 
experience confusion and distress due to the ‘‘sense of uncontrollable sexual urge” that is 
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sometimes experienced by PCOS patients (Gorzynski & Katz, 1977).  Further research has 
linked PCOS with ‘abnormal’ sexuality.  One such study was conducted by Meyer and Zerssen 
(1960) who recognized a ‘‘deep rooted insecurity’’ concerning the sexual role of patients with 
hirsutism, especially those with PCOS. Another study noted that dating and romantic interests 
are frequently disrupted due to the psychological problems associated with PCOS and the 
insecurity and confusion felt by these women (Money & Clopper, 1974). This conclusion was 
also supported by the research of Michael et al. (1996) which suggested that the physical 
unattractiveness felt by many PCOS patients affected these women’s  ‘abnormal’ sexual desires. 
The overall theme that keeps appearing is that failure to live up to the expected or ideal views of 
femininity leads to deviant sexuality in PCOS women (Michael et al., 1996).  
 The chronic, complex, and often frustrating nature of PCOS frequently leads to negative 
psychological consequences which subsequently lead to decreased motivation and confidence 
(Garad et al., 2011). This loss of motivation and confidence is very detrimental for PCOS 
patients because the most important aspect of treatment is lifestyle modification because an 
individual can make positive changes to aid in the maintenance of PCOS and insulin resistance. 
If motivation is lacking, it is harder for these women to make the necessary changes in their 
lives, such as following dietary, pharmaceutical, and physical activity guidelines (Barnard et al., 
2007). A vicious cycle has also been noted involving treatment compliance and body image 
distress. Many PCOS patients, especially those who struggle with weight and appearance traits, 
such as hirsutism or acne, have been seen to experience more body image distress. This distress 
has led many women to feel uncomfortable in certain situations, especially exercise participation, 
this, along with the decreased motivation, perpetuates the negative consequences related to 
PCOS, obesity, and psychological distress. In fact, Liao et al. (2008) reported that about half of 
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the PCOS women interviewed stated that they often avoid physical activity because of the way 
they felt about their size. While some individuals are not aware of the psychological implications 
of PCOS, it is vital to inform women of these risks, and to incorporate psychological 
management into the treatment plan because treatment of psychological symptoms, particularly 
depression, will also have a positive impact on other features of PCOS, including weight 
management, insulin resistance, and endocrine disturbances. It has also been suggested that 
treating the depression may help in preventing comorbid conditions from arising or from getting 
out of control (Barnard et al., 2011).  
 One source noted the importance psychological symptoms for PCOS women by 
mentioning that all of the necessary personal changes involved with PCOS cannot be carried out 
without the desire of the individual. This source suggested that all women should be screened for 
disordered eating behaviors at time of diagnosis, before referrals or weight-loss treatments are 
suggested. These recommendations were given because there has been a higher incidence of 
eating disorders found in PCOS women, with binge eating and fasting being seen most often. 
Proposed explanations for this trend include the idea that many eating disorders and body image 
problems arise during adolescence which is also when many of the symptoms of PCOS first 
become prominent. The added physical and psychological stress of PCOS symptoms during this 
vulnerable time is believed to be a major contributor to this trend (Scalzo & McKittrick, 2000). 
Barnard et al. (2007) proposed that because there is a greater risk of obesity in PCOS women, 
there is also a higher risk of eating disorders. Another reason for disordered eating in PCOS is 
because a large part of lifestyle modification is diet and nutrition. PCOS women are told that 
they should follow food guidelines in order to help in alleviation of certain PCOS symptoms. 
The body image distress that many PCOS women feel eventually leads to loss of control of 
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healthy eating, and perhaps activity habits, which leads to further weight gain and various eating 
disorders (Liao et al., 2008). Some women become meticulous about food selection and the 
intake process to the point that it becomes very unhealthy. While these women may feel that if 
they severely limit themselves, they will become healthier and will have fewer PCOS symptoms 
or a lower severity of symptoms, the truth is that the extreme peaks and valleys of energy 
associated with these extreme eating habits contribute to and worsen insulin resistance. This is 
the case whether the individual is lean or obese (Scalzo & McKittrick, 2000).  
  Another source of distress is the treatment process for PCOS because different doctors 
take diverse approaches, and each treatment option will produce variable outcomes in different 
patients. With PCOS, women are more likely to develop serious life-long comorbidities, to take 
larger quantities of medicine, to have higher BMI, and to experience only partial success in 
alleviating or eliminating PCOS symptoms. Because of these facts, it is logical to note that 
PCOS women show a higher incidence of psychological morbidity. It has been suggested that 
psychological treatment should be carried out on a case-to-case basis in order to address the 
aspects of the disease that are most troubling to each individual (Barnard et al., 2007). Support 
for this proposal comes from a study in which psychological counseling was shown to improve 
body image, regardless of weight loss (Rosen, 1996). 
 With all of these troubling aspects of PCOS, it makes sense, when interviewed, the 
majority of PCOS women noted pervasive feelings of “freakishness”, “abnormality”, and of not 
being a “proper” woman. According to the women interviewed, the ideal woman would have 
regular menstruation, the ability to bear children, and would have smooth, hairless faces; many 
of these women did not meet their own criteria. Due to the women’s symptoms of hirsutism, 
menstrual irregularities, and infertility, the women stated that they felt less “feminine” and 
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“different” from other, “normal”, women. This source suggested that because PCOS has been, 
and still is, widely unknown by the general public, it remains a “deeply stigmatizing condition", 
a "theft of womanhood.” The stigma placed on PCOS has may serious implications for PCOS 
patients, whether or not they conform to “feminine norms" (Kitzinger & Willmott, 2002).  
 An added frustration and deterrent of psychological well being is the diagnostic process. 
Overall, PCOS is diagnosed based on the presence of signs and symptoms of hyperandrogenism 
when seen in conjunction with menstrual irregularities while excluding other possible causes. 
Clinical signs of hyperandrogenism include, but are not limited to, acne, hirsutism, and 
abdominal obesity (Scalzo & McKittrick, 2000). However, diagnosis of PCOS can be very 
difficult for a variety of reasons. One such reason is that there is no one specific test or one 
universally accepted criteria that are used to diagnose PCOS, but rather, there are multiple tests 
and criteria that may be used. To add to the confusion, many of these tests show inconclusive 
results by themselves and must be used in conjunction with each other in order to come up with a 
diagnosis (Tsilchorozidou, 2004). The lack of one universally-accepted diagnostic test causes 
doctors to use a patient's clinical history and a few lab tests in order to make a diagnosis 
(Sheehan, 2004). While this may be enough to make a diagnosis, it leaves a lot of room for 
uncertainty and error which helps to explain why PCOS is often misdiagnosed or goes 
undiagnosed (Scalzo & McKittrick, 2000). Another difficulty with diagnosis is that many 
symptoms of PCOS are associated with many other diseases; therefore, doctors have to do 
differential diagnoses in order to rule out other possible causes of the symptoms (Sheehan, 
2004). Conditions such as thyroid dysfunction and hyperprolactinaemia must be excluded 
biochemically while other conditions, including Cushing's syndrome, androgen-producing 
tumors, and nonclassic congenital adrenal hyperplasia, need to be ruled out clinically. Not every 
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PCOS woman exhibits the same symptoms or the same degree of symptoms which increases the 
complicated nature of diagnosis, and different doctors may take different approaches to the 
diagnostic procedure. Because of this, clinical practice and treatment suggestions are also varied 
and inconsistent, with certain aspects of the disease often being neglected, such as the 
psychological issues and the focus on lifestyle modification.  In addition, PCOS, although 
common, is still little known by the general population; therefore, a woman may be having 
symptoms of PCOS and not recognize the possibility of PCOS. The public is also not well 
informed about the serious implications that PCOS, and its related insulin resistance, has. This 
lack of information, could lead to even more serious complications if the correct diagnosis and 
treatment are not performed. Because of the heterogeneity of this syndrome, PCOS women may 
present with varied symptoms to many different types of doctors who do not have expertise in 
PCOS. The variety of medical professionals who treat potential PCOS patients is important 
because health professionals lack the in-depth knowledge of PCOS that is required to recognize, 
understand, and diagnose the disease (Garad et al., 2011).  
  As mentioned previously, different women have different PCOS symptoms and to 
different degrees; along with this, there is the matter of certain test results being skewed or 
inconclusive. For example, PCOS causes increased androgens; therefore, women's blood tests 
should indicate increased testosterone, but testosterone may appear normal in these blood tests 
because birth control lowers total testosterone. This fact can make interpretation of test results 
difficult and diagnosis challenging. In fact, birth control can affect many biochemical or 
hormonal levels which may prevent certain PCOS symptoms from appearing on tests. Women 
may also develop symptoms at different times of their lives with some women developing 
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symptoms at menarche and others developing symptoms later in life, sometimes after gaining a 
certain amount of weight (Sheehan, 2004).  
 Another type of test whose results can be confusing is the pelvic ultrasound. The 
approach to ultrasound and lab evaluation is widely varied without any consensus as to which 
method is the best, even among experts (Sheehan, 2004). Much confusion is due to the fact that 
many women have polycystic ovaries but do not have polycystic ovarian syndrome. 
Approximately twenty-five percent of women have polycystic ovaries on ultrasounds, but only 
four to twelve percent of women have PCOS, and some PCOS women may not have cysts on 
their ovaries (Tsilchorozidou, 2004). Therefore, an ultrasound showing ovarian cysts is not 
needed to diagnosis PCOS, which can be very confusing for consumers and patients who are not 
familiar with PCOS (Scalzo & McKittrick, 2000).  Another complication is that ten cysts 
measuring greater than or equal to two to eight mm around a dense core of stroma or scattered 
within an increased amount of stroma must be present in order to diagnose PCOS 
(Tsilchorozidou, 2004). The difficulty of using this criterion can be seen in the following 
example. If a woman has eight cysts with some being four mm in diameter and some being one 
mm in diameter, is it truly correct to say that this woman does not have PCOS? This example 
serves to show that, while these criteria are helpful in theory, they can be difficult to use in 
practice as lines are blurred between what is and what is not PCOS. In addition, new information 
about PCOS is continuing to be found, thus causing changes in criteria and leading to increased 
diagnostic complications in determining a set criteria.  
 One of the major signs or symptoms of PCOS is irregular menstruation; however, not all 
PCOS patients exhibit this ovulatory dysfunction. In fact, up to forty percent of women with 
oligo-ovulation secondary to PCOS can exhibit a history of "normal menstruation.” This 
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complicates matters because periodic vaginal bleeding cannot be assumed to involve ovulation if 
the woman is suspected of having PCOS (Azziz, 2007).  
 Various combinations of tests and diagnostic methods may be utilized, and results can be 
difficult to interpret especially when using tests to assess insulin resistance. None of the tests 
used to for insulin resistance are very specific or sensitive, and some professionals even argue 
that the only assessments needed are fasting lipids and glucose (Sheehan, 2004). Another 
difficulty to diagnosing insulin resistance is that twenty-five percent of normal subjects have 
insulin action values that overlap with those from insulin resistant individuals because there is a 
wide range of insulin sensitivities that are seen in "normal" individuals, individuals not 
diagnosed with IR (Dunaif, 1997). New strides are being made, and it is now recognized that a 
two hour glucose tolerance test may be a better predictor of insulin resistance (IR) than fasting 
glucose. However, this better diagnostic practice is still not universally used, but it may cause the 
betterment of therapeutic decisions, as its use becomes more widespread because this test is 
extremely useful in determining an individual's risk for type two diabetes (Sheehan, 2004). The 
betterment of diagnostic testing is extremely important in relation to PCOS because early 
diagnosis can lead to prevention and better management of the possible risks associated with 
Polycystic Ovarian Syndrome.  
 PCOS is a complicated and distressing disorder on its own, but what many people do not 
realize is that PCOS can increase a woman's risk for many other serious health problems. The 
greatest concerns are cancer, cardiovascular disease, and insulin resistance, which can lead to 
type two and gestational diabetes. PCOS can potentially increase a woman's risk for endometrial 
carcinoma by three-fold, due to infrequent periods which cause endometrial buildup and possibly 
endometrial cancer (Sheehan, 2004). However, how common these endometrial abnormalities 
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are remains to be seen, and more research is needed, on a larger-scale, in order to make more 
accurate assertions (Azziz, 2007).  
 Cardiovascular Disease is another area of concern in which more research is necessary to 
truly determine its association with PCOS. Research has shown that, due to the many strains that 
insulin resistance and obesity put on the body, a PCOS patient exhibiting these two conditions 
has an increased risk of coronary artery disease, dyslipidemia, and hypertension (Sheehan, 2004; 
Dunaif, 1997). In particular, the hyperinsulinemia associated with PCOS can cause abnormal 
lipid metabolism, leading to elevated LDL and triglyceride levels and decreased HDL levels 
(Scalzo & McKittric, 2000).  This abnormal lipid metabolism causes the body to enter a state in 
which there is an irregular or elevated level of lipids or lipoproteins in the blood, known as 
dyslipidemia (“Medical Dictionary,” 2013). All of these factors contribute to the fact that, as 
much as, a seven-fold increased risk of myocardial infarction and a six-fold increased risk of 
coronary artery calcification have been found in PCOS women(Sheehan, 2004). Myocardial 
infarction refers to an episode in which some of the heart's blood supply is severely cut off or 
restricted, causing the heart muscle to suffer and die from lack of oxygen (“Medical Dictionary,” 
2013). Increased insulin can also lead to abnormal clotting factors, which also increases an 
individual’s risk for developing heart disease (Scalzo & McKittrick, 2004). Currently, adequate 
evidence for an increased incidence of cardiovascular disease and events in PCOS in still 
lacking, but it is certain that these women are at a higher risk for developing cardiovascular 
problems and/or complications (Azziz, 2007). These increased risks for developing CVD are 
extremely important and must be monitored because CVD disease is currently the number one 
killer of women in the United States, with more than one in three adult females in the U.S. 
having some form of CVD (Gillespie et al., 2013). 
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 Another cause of many deaths for women in the U.S. is diabetes. Currently, 12.6 million, 
or 10.8 percent of, women in the U.S., over the age of twenty, have diabetes, and diabetes is the 
seventh leading cause of death as of 2011 (Centers for Disease Control and Prevention, 
2011).One source stated that thirty-one percent of PCOS women have impaired glucose 
tolerance and seven and a half to sixteen percent have type two diabetes with PCOS women 
being three to seven times more likely to develop type two diabetes than weight matched 
controls (Sheehan, 2004; Scalzo & McKittrick, 2000). Even at seven and a half percent 
incidence, these women display a four-fold increase in prevalence of type two diabetes when 
compared to women of similar age in the general population. This increased prevalence of type 
two diabetes is correlated with the insulin resistance and obesity seen in PCOS patients (Azziz, 
2007). Increased insulin resistance and obesity also put PCOS women at a ten-fold increased risk 
for gestational diabetes mellitus (Sheehan, 2004).   
  Because there are many secondary disorders, the exact etiology of PCOS is still 
widely unknown, women exhibit different symptoms to varying degrees, and there is not one set 
protocol for diagnosing PCOS, treatment options are diverse, and response to the treatment 
option chosen is variable. Not all patients will respond to treatment, and when a patient does 
respond to treatment, the responses are often incomplete with no alleviation of some symptoms 
and marginal mitigation of others. Another difficulty in the management process is that a six to 
twelve month period of time is needed before a professional can determine the effectiveness of a 
treatment option (Sheehan, 2004).  The complexity of treatment and the complexity of diagnostic 
process are similar in that there is no universally accepted method or recommendations. 
Therefore, various treatments will be prescribed and suggested treatment will be based on each 
individual case.   
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  The main goal of treatment is to manage or alleviate a patient's symptoms. Different 
treatment options may be suggested according to which symptoms are most prevalent or 
depressing for a particular PCOS patient. According to one document, the focus of management 
should be on education and support with a strong emphasis on healthy lifestyle in order to 
manage and prevent major negative consequences of PCOS. This same source also stated that 
appropriate medical therapies should be implemented when needed (Sheehan, 2004). One such 
medical therapy often used in treatment is Metformin. Metformin is an oral anti-diabetic drug, 
often prescribed for type two diabetes, that suppresses glucose production by the liver, lowering 
plasma glucose levels (Dunaif, 1997). This insulin sensitizing drug has been shown to lead to 
amerlioration of many of the symptoms seen with PCOS including weight gain, fatigue, 
headaches, hirsutism, and menstrual abnormalities. While the benefits of Metformin are more 
pronounced when accompanied by weight loss, this drug has been shown to decrease 
hyperandrogenism and hyperinsulinemia regardless of weight loss (Scalzo & McKittrick, 2000).  
Metformin, along with other insulin sensitizers, can potentially prevent or delay the development 
of type two diabetes in PCOS patients. There is also evidence that Metformin, when used 
throughout pregnancy, decreases the rate of gestational diabetes mellitus from about three to 
thirty percent (Sheehan, 2004). Certain studies have shown Metformin's effectiveness of safely 
decreasing the amount of first-trimester miscarriages seen in PCOS women. In addition, there are 
currently no known adverse fetal outcomes amounting from the use of Metformin during 
pregnancy (Tsilchorozidou, 2004). Metformin and lifestyle modification increases SHBG which 
correlates with improved insulin sensitivity resulting in a decrease of free testosterone available 
and a decline in testosterone action (Sheehan, 2004).  
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 Another common medical treatment for PCOS is the use of oral contraceptives (OCP). 
Oral contraceptives can be used to help with menstrual irregularity, endometrial buildup, and 
hyperandrogenism due to ovarian androgen production (Dunaif, 1997). Oral contraceptives have 
been shown to decrease SHBG and gonadotropin production which, in turn, decreases the 
bioavailable testosterone by forty to sixty percent (Sheehan, 2004). Gonadotropin is a hormone 
that stimulates the growth and activity of the gonads (“Medical Dictionary,” 2013). This is 
extremely important for PCOS women because many of the distressing symptoms are caused by 
an increase in a woman's testosterone levels. Birth control has also been shown to have some 
affect on amelioration of depression associated with PCOS. In one study, the rate of depression 
in untreated patients was sixty-six percent while the rate of depression in patients taking birth 
control was twenty-nine percent (Rasgon, 2003).  
 While oral contraceptives are often used with a significant amount of success, a number 
of PCOS patients may be advised against taking birth control because OCPs can worsen 
hypertriglyceridemia which is already a problem for insulin resistant individuals (Roush, 2010).  
Most OCPs have also been shown to produce IR in normal women, especially oral 
contraceptives that contain triphasic progestin (Dunaif, 1997). Hypertriglyceridemia causes 
elevated triglycerides or fat levels often leading to obesity and other related health consequences 
which simply perpetuate the vicious cycle involving PCOS, obesity, and insulin resistance 
(Sheehan, 2004).  
 One source focused on the treatment of the physical and psychological aspects of PCOS 
and suggested that an individual should consider getting counseling after diagnosis (Sheehan, 
2004). Multiple sources also stated that much of the psychological distress associated with PCOS 
could be ameliorated with improved communication of information between doctors and 
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patients, including an accurate online source of information which could improve the quality of 
life and self-management of many PCOS women. Currently, many patients say that the amount 
and quality of information they received about PCOS and specific aspects of the disease were 
sub-par and wished that they had been given better information in order to be able to use it in 
their management techniques (Ching et al., 2007).   
 There are four issues related to PCOS that are targeted in treatment. These four issues 
are: controlling hirsutism, regulating menses, managing IR and its associated risks, and dealing 
with fertility issues. There are numerous techniques in existence that are designed to help with 
each specific symptom of concern. Various sources give different suggestions on how the 
treatment of PCOS should be handled or which method of treatment is best, but overall the most 
important aspect of treatment is that it must be tailored to the specific patient. Individualization 
of care is extremely important in PCOS because of the extreme heterogeneity of the disease. 
Care should focus on symptoms and the short and long term metabolic, reproductive, and 
psychological features of the disorder (Sheehan, 2004).  
 While treatment may vary from person to person, depending on her symptoms, one 
suggested treatment is always the same, lifestyle modification. There is no medical option that 
fully reverses the underlying hormonal disturbances and treats all of the features of PCOS, but 
lifestyle modification can drastically improve the majority, if not all, of the aspects of PCOS and 
its associated symptoms and conditions (Garad et al., 2011).  
 It is well known that exercise and healthy eating habits are important to an individual's 
overall health, what some people may not realize is how important each of these things is in 
relation to Polycystic Ovarian Syndrome. Lifestyle modification is the first line of treatment for 
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PCOS patients because weight loss, and the prevention of weight gain, are vital to the 
improvement of PCOS symptoms, and a better quality of life (Garad et al., 2011). Lifestyle 
modification should take precedence regardless of whether a patient is lean, obese, taking 
medications, or not.   
 According to certain sources, increased physical activity and change in diet is the best 
combination for improvements in the many realms of health, with better results being seen with 
this combination than with exercise or diet alone. The addition of an exercise regiment has been 
shown to result in better long-term weight management (Garad et al., 2011; Thomson et al., 
2011). When advising a patient about a lifestyle treatment plan, the doctor must create an 
individualized system for each patient due to the very personal nature of the disease. An 
enjoyable exercise program should be chosen for the patient, goals should be realistic, and 
changes must be able to be sustained (Scalzo & McKittrick, 2000; Galletly et al., 1996). While 
the exact lifestyle plan for each woman may differ, certain suggested lifestyle changes will 
benefit most patients. For example, each patient should modify her diet by decreasing her total 
energy intake, reducing her stress, considering group support, meeting with a dietetics 
professional, and increasing her physical activity level (Sheehan, 2004; Scalzo & McKittrick, 
2000).  Lifestyle modification is also "the least expensive, least invasive, and safest way to 
control weight and insulin levels" (Scalzo & McKittrick, 2000, p.958). Diet and exercise have 
also been shown to be a very effective form of treatment, with even just a five to ten percent 
reduction in weight, creating positive changes in the realms of metabolic, reproductive, and 
psychological symptoms (Garad et al., 2011).  
 There are numerous benefits related to lifestyle modification, and improvements can be 
seen in regards to many of the distressing symptoms seen in PCOS. By increasing one's level of 
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physical activity and changing her diet, she can lose weight and decrease her risk of developing 
cardiovascular disease (Sheehan, 2004).  Simply by doing moderate physical activity, including 
at least thirty minutes of structured exercise a day, weight loss and weight maintenance is likely 
to occur along with improvements in clinical outcomes (Garad et al., 2011). Research has found 
that lifestyle modification can lead to better health through reduction in central fat and 
improvement in insulin resistance even without weight loss; however, better results are seen 
when weight loss occurs (Garad et al., 2011; Huber-Buchholz et al., 1999). Improvement in 
nutrition and physical activity often result in weight loss, and reduction in abdominal fat leads to 
restoration of ovulation in many women (Huber-Buchholz et al., 1999; Moran et al., 2003).  
 One important aspect of lifestyle modification is a woman's diet, and through this 
literature review, it was gathered that no single diet has been proven to be best for PCOS 
patients. Moran et al. (2003) compared various diets and found a reduction in abdominal fat, 
independent of diet composition. Usually an individual experiences an reduction in 
hyperlipidemia, IR, miscarriages, and hyperglycemia, an increase in frequency of ovulation, and 
possibly restoration of fertility with weight loss, even if the weight loss is less than ten percent of 
the individual's initial weight (Dunaif, 1997; Thomson et al., 2011). Decreased levels of one's 
free androgen index (FAI) and testosterone along with increased SHBG have also been seen in 
conjunction with weight loss (Thomson et al., 2011). Huber- Buchholz et al. (1999) also noted 
that marginal weight loss improves menstrual function, hopefully leading to long term 
restoration of reproductive potential and improved likelihood of pregnancy. It has been found 
that the restored fertility, and other reproductive benefits, seen with weight loss are due to the 
decrease in circulating insulin levels. Improvements in various reproductive parameters have also 
been seen when other methods are used to decrease insulin levels, suggesting that agents that 
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lowering one's insulin levels, through the improvement of insulin sensitivity, may provide a new 
therapeutic modality for PCOS (Dunaif, 1997).   
 Not only does lifestyle modification affect a woman physically, but it also influences her 
mentally. Various lifestyle modifications have been found to create positive changes in regards 
to the many psychological aspects including mood and psychological well-being. Studies have 
shown that lifestyle modification leads to decreased levels of depression and anxiety and 
increased self-esteem and Health Related Quality of Life (HRQOL) scores for women with 
PCOS (Thomson et al., 2011). One program, that involved a brisk-walking regimen, found that 
women who completed the program had reduced body image distress, despite changes in BMI 
(Liao et al., 2008). Another program used exercise, healthy diet information, and group 
discussion sessions, and found that after the completion of the twenty-four week program there 
was significant improvement in the women's self-esteem, self-image, and depression. This study 
also did a two year follow-up in which improvements were found to be maintained and further 
weight loss was seen in many of the patients (Galletly et al., 1996). This successful maintenance, 
seen in the study of Galletly et al.(1996), supports the suggestion that this combination of 
treatment options should be used for all PCOS women, due to its great success and fairly easy 
process.  The results of this research also supported the idea that with an increase in information, 
PCOS women may experience improved quality of life and self management (Ching et al., 2007; 
Galletly et al., 1996).  
 Interestingly, it has been found that moderate exercise is as effective as vigorous exercise 
at improving some of the PCOS symptoms, and it is possible to see an improvement simply by 
incorporating moderate-intensity lifestyle activity, without the necessity of structured aerobic 
exercise. Because of these results, researchers suggest that doctors should use a three point 
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approach to increasing physical activity. According to this source, a physician should stress the 
importance of decreasing sedentary behaviors, increasing lifestyle activity, and initiating 
moderate exercise (Sheehan, 2004). It is also vital that an individual maintain her weight loss, 
and because of this, self-monitoring is an important part of the lifestyle aspect of treatment 
because more intense action must be taken if weight increases, even if it just by a small amount 
(Garad et al., 2011).  
 The diet portion of treatment is equally important, and the most important aspect of diet 
seems to be caloric restriction. By reducing a person's intake by 500-1000 calories per day, a 
seven to ten percent reduction in weight was seen, over a six to twelve month time period in a 
study done by Garad et al. ( 2011). Ongoing research is being conducted to determine which type 
of diet is best for a PCOS patient, but no conclusive results have been found. Different projects 
have looked at, or are currently comparing, diets such as low glycaemic index (GI) diets, high 
protein diets, and low protein diets. While each type of diet has its benefits, there have been no 
significant results found to favor any one diet plan over the other. In fact, in one study, equal 
improvements were seen in both groups of women, those with high protein intake and low 
protein intake.  There was no difference in the changes seen in weight or abdominal fat loss, lipid 
and glucose metabolism, total fat mass, total lean mass, testosterone, SHBG or fasting insulin 
(Moran et al., 2003). Overall, a PCOS patient should eat multiple, small, balanced meals a day 
with the inclusion of high fiber foods, whole grains, healthy fats, lean protein, fruits, and 
vegetables, while limiting the amount of sugar intake (Scalzo & McKittrick, 2000). Meals should 
be balanced in order for your body to carry out the optimum insulin secretion and metabolism by 
eating foods that will cause a slower rise in blood sugar levels, and prevent large peaks and 
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valleys in insulin and glucose levels. These results point to the conclusion that energy restriction 
is what really matters in relation to diets for PCOS patients.  
 These improvements associated with lifestyle modification help to protect against the 
development of CVD and diabetes, limit morbidity, and reduce mortality.  
 The importance of PCOS education cannot be stressed enough. With early diagnosis and 
adequate information, individuals can prevent serious complications and minimize the 
distressing symptoms that accompany PCOS. With the great prevalence of PCOS, and the lack of 
knowledge in the population, many women are set up to struggle with this mysterious disease 
while feeling completely alone. Women with PCOS have also complained that they have 
received "less than optimal" information about the syndrome, including its short and long-term 
implications. Because of these facts and other research, it had been suggested that information 
programs for PCOS would be very beneficial, especially in the relation to Quality of Life (Ching 
et al., 2007). Ching et al. (2007) also noted that these types of programs may promote "proactive 
self-management" of women's PCOS symptoms. While many strides still need to be made in this 
area, the creation of online support groups that provide a plethora of accurate information are a 
step in the right direction.  
 Along with increased information, an increase in screening could prove to be a cost-
effective manner by which to prevent and manage PCOS. If testing for PCOS became a routine 
process as part of a woman's yearly exam, cases would be able to be diagnosed earlier, leading to 
earlier treatment, and hopefully amelioration and prevention of negative consequences associated 
with PCOS. Azziz's (2007) study showed just how cost-effective increased diagnostic evaluation 
can be. The study used a 6.6% incidence rate to look at the annual cost of PCOS in 
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reproductively-aged women in the U.S. This study found that about 4.37 billion dollars are spent 
annually to evaluate and provide care to PCOS patients in the U.S. Not all possible aspects of 
PCOS were looked at, but the cost of many were estimated. The estimations showed that 40.4% 
of this cost was due to type two diabetes treatment, and only 2.3% of the expense was due to 
diagnostic measures (Azziz, 2007). These results are very significant because they show that the 
overall cost of PCOS could be greatly decreased by finding and using early and accurate 
diagnostic techniques. If these measures are carried out, the number of PCOS women with type 
two diabetes would be likely to decrease, easing the economic burden of PCOS. 
 As mentioned previously, there are still many questions about PCOS that remain 
unanswered. However, certain studies are looking into many aspects of PCOS. Some researchers 
are proposing possible causes; others are trying to determine which diet and exercise regiment is 
best; while others are exploring the avenues of education, prevention, and associated disorders. 
Regardless of the current state of information, it can be said that there will be a brighter future 
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